Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

NCT04988009 | Recruiting

• 2 other identifiers: 2020-0493NCI-2020-07493
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.

Conditions

Central Nervous System Neoplasm; Leptomeningeal Neoplasm; Metastatic Malignant Neoplasm in the Brain; Primary Brain Neoplasm

Outcome Measures

Primary Outcomes (1)

• Survey response to question 6 of the quality of care survey ("I felt I received good medical care during this encounter")

  Survey responses will be summarized by ordinal category as counts with percentages, separately by group. Will separately estimate the proportion of each ordinal level of each group with 95% confidence interval.

  through study completion, an average of 1 year

Secondary Outcomes (6)

• Quality of Care Survey

  through study completion, an average of 1 year

• Patients and clinical characteristics

  Baseline

• Interactive time spent during visit

  through study completion, an average of 1 year

• Time from visit order placement to visit occurring

  through study completion, an average of 1 year

• Domains of patient care addressed during a visit, including treatment planning, symptom burden, and goals of care

  through study completion, an average of 1 year

Study Arms (1)

Observational (survey, medical chart review)

Patients complete a survey related to their perceived quality of care via telephone and have their medical chart reviewed prospectively.

Other: Electronic Health Record Review; Other: Survey Administration

Interventions

Electronic Health Record Review OTHER

Review of medical chart

Observational (survey, medical chart review)

Survey Administration OTHER

Complete survey

Observational (survey, medical chart review)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with encounters at the Brain and Spine Center between 4/20/2020 and either (1) 8/30/2020 or (2) date that the state of emergency secondary to the COVID-19 pandemic is declared terminated in the United States of America- whichever date is earlier

You may qualify if:

• Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease
• Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be
• An in-person visit
• A telemedicine appointment

You may not qualify if:

• Encounter occurred with the assistance of official language translation support
• Patients with telephone encounters (without interactive video)
• New patient or consult visits
• Neither patient nor caregiver present during the visit are available or able to answer survey questions

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

• University of Texas MD Anderson Cancer Center Website

MeSH Terms

Conditions

Central Nervous System Neoplasms; Meningeal Neoplasms; Brain Neoplasms

Condition Hierarchy (Ancestors)

Nervous System Neoplasms; Neoplasms by Site; Neoplasms; Nervous System Diseases; Brain Diseases; Central Nervous System Diseases

Study Officials

• Barbara J O'Brien, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Barbara J O'Brien, MD

CONTACT

713-794-4380; bjobrien@mdanderson.org

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 7, 2020
• First Posted: August 3, 2021
• Study Start: August 20, 2020
• Primary Completion (Estimated): December 31, 2026
• Study Completion (Estimated): December 31, 2026
• Last Updated: March 5, 2026

Record last verified: 2026-03

Locations

US (1)